-
Study aim
-
- Determination the effect of platelet-rich plasma injections and triadent oral paste on the VAS and Thongpressam scale of patients with oral lichen planus on day 0, 7,14, 30, 60
-
Design
-
Clinical trial phase 1-2 with control group, with parallel groups, randomized trial with double blinded outcome assessment on 15 patients. block randomization will be used.
-
Settings and conduct
-
This study will be done on patients with oral lichen planus lesions who will be referred to Oral and Maxillofacial Disease Department of Shiraz Dental School. In one side of intervention group, the paltelet rich plasma and triadent will be prescribed and for control side just triadent. The assessor of outcomes and statistical analysor will be blinded to the type of prescribed medication.
-
Participants/Inclusion and exclusion criteria
-
Inclusion: The patients with histopathology and clinically conformed atrophic or erosive oral lichen planus
Exclusion: The patients with history of other inflammatory diseases, malignancies or even dysplastic lesions
-
Intervention groups
-
Intervention group: The prepared PRP will be injected around the lesion and intra lesion with anesthesia by insulin syringe twice (once every week) during first two weeks beside twice in a day use of triadent oral paste 0.1% (Raha Pharmaceutical company- Iran) .The VAS and thongpressom scale will assed the pain, size (days 0, 7, 14, 30, 60).
Control group: The patient with two-sided OLP will be under routine treatment during the study. Both sides OLP lesions will be treated by triadent oral paste 0.1% (Raha Pharmaceutical company- Iran) twice in a day. The lesion on control side will only receive triadent.
The VAS and thongpressom scale will assed the pain, size on days 0, 7, 14, 30, 60.
-
Main outcome variables
-
Pain, size